Such-Lupe

Ad hoc and press releases

Here, we have compiled the press and ad hoc releases from the past years. All releases can be viewed directly on the screen or downloaded in PDF format.

2010 

11/11/2010
Corporate News
STADA: Group sales increased in 1-9/2010 – adjusted EBITDA went up considerably – high burdening one-time special effects – confirmation of outlook for 2010
More information
 
09/28/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Burdening special effects in the amount of approx. EUR 29.5 million before taxes as a result of liquidity problems of Serbian wholesalers
More information
 
09/03/2010
Corporate News
STADA: Executive Board structure secured for the long term
More information
 
08/12/2010
Corporate News
STADA: Good Group development as expected in H1/2010 – Group sales +3% – Net income +4% – EBITDA +15% – Initial successes with implementation of "STADA – build the future" – Outlook remains positive for 2010
More information
 
07/26/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Dr. Axel Müller will be the new Chief Production and Development Officer – Christof Schumann resigns from Executive Board responsibilities
More information
 
06/08/2010
Corporate News
STADA AGM 2010: Focus on long-term growth targets for 2014
More information
 
06/07/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA's targets for 2014: EBITDA ca. EUR 430 mio with sales of ca. EUR 2.15 bn – “STADA – build the future” aiming to sustainably increase earnings introduced – total burdening one-time special effects of ca. EUR 50 mio, of which ca. EUR 10 mio in 2010
More information
 
05/12/2010
Corporate News
STADA: Very good results in Q1/2010 – Group sales +5% – Net income +17% – EBITDA +12% – Outlook remains positive for 2010
More information
 
05/10/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Appointment of Executive Board member Christof Schumann not extended
More information
 
04/14/2010
Corporate News
STADA: STADA Arzneimittel AG successfully places EUR 350 million bond
More information
 
03/30/2010
Corporate News
STADA 2009: Good results in a difficult environment – net income significantly improved – positive outlook for 2010
More information
 
03/01/2010
Ad hoc release

Ad hoc release according to § 15 WpHG:

STADA: Net profit significantly improved – dividend set for further increase based on good preliminary results for 2009 – Positive outlook for 2010
More information
 

 

(c) 2012 STADA Arzneimittel AG, Stadastraße 2-18, 61118 Bad Vilbel, Telefon 06101 603-0, Fax 06101 603-259, e-Mail: info@stada.de